How much did Kytopen raise?

Kytopen raised $3.1 Million in a Seed round on November 6, 2020.

Where is Kytopen based and how big is it?

Kytopen is based in Cambridge, Massachusetts, United States. Fundz records about 34 employees.

Who are the decision-makers at Kytopen?

Fundz holds 3 contacts at Kytopen, including the Independent Technical Consultant - Cell & Gene Therapy / Regenerative Medicine. Names and contact details are shown to Fundz members.

Kytopen Corp. reported raising $3.1 Million in an initial SEC Form D filing, from an offering of $4 Million

PRIVATENov 06, 2020$3.1M of $4M raised

Amount Raised

$3.1 Million

$3.1 Million sold, per SEC Form D (first sale Nov 6, 2020)

Round Type

Seed

CambridgeBiotechnology

Quick answer

Kytopen raised $3.1 Million in a Seed round, dated November 6, 2020. Kytopen is based in Cambridge, Massachusetts, United States.

How much did Kytopen raise?: Kytopen raised $3.1 Million in a Seed round on November 6, 2020.
What does Kytopen do?: Kytopen, a spin-out of Prof.
Where is Kytopen based and how big is it?: Kytopen is based in Cambridge, Massachusetts, United States. Fundz records about 34 employees.
Who are the decision-makers at Kytopen?: Fundz holds 3 contacts at Kytopen, including the Independent Technical Consultant - Cell & Gene Therapy / Regenerative Medicine. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Kytopen that raised within 45 days of this round, from Fundz verified event records.

Novel Microdevices raised $725K (Seed) on December 21, 2020.
Hopewell Therapeutics raised $7.8M on December 21, 2020.
PROLUNG INC raised $182K (Seed) on December 21, 2020.
OnKure Therapeutics, Inc. raised $47M on December 21, 2020.
OSE Immunotherapeutics raised $5.6M (Funding Round) on December 18, 2020.
GENENEWS LTD raised $198K (Seed) on December 18, 2020.

Who to call at Kytopen, and when

A new round usually means Kytopen is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Kytopen raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Kytopen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kytopen. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kytopen

Location

Cambridge, Massachusetts, United States

About

Kytopen, a spin-out of Prof. Cullen Buie’s lab at MIT, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which seamlessly links the discovery, development, and manufacturing phases of cell engineering. Flowfect®, a gentle, non-viral delivery method unlocks new therapeutic approaches, by engineering immune cells with minimal disruption, preserving the functionality and viability of human cells and enhancing the cell’s biology. The Flowfect® platform accelerates therapies from the bench to the clinic through flexibility and scalability, which drives higher cell yields, faster approvals, and better outcomes from potentially curative cell-based treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kytopen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

3 contacts

Verified contactsDaniel W., Independent Technical Consultant - Cell… hidden hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Kytopen's next move

See what Strategic adds

Kytopen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.